Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
XERS | Xeris Biopharma Holdings, Inc. | JOHNSON JOHN | Director | Mar 18, 2024 | Option Exercise | $1.99 | 215,600 | 429,044 | 751,412 | Mar 18, 2024, 05:32 PM | |
XERS | Xeris Biopharma Holdings, Inc. | Schmid John P. | Director | Mar 14, 2024 | Buy | $2.16 | 4,500 | 9,720 | 11,000 | Mar 14, 2024, 09:03 PM | |
XERS | Xeris Biopharma Holdings, Inc. | SHERMAN JEFFREY W | Director | Nov 27, 2023 | Buy | $1.87 | 5,400 | 10,098 | 5,400 | Nov 29, 2023, 04:09 PM | |
XERS | Xeris Biopharma Holdings, Inc. | HALKUFF DAWN | Director | Nov 20, 2023 | Buy | $1.84 | 5,410 | 9,954 | 5,410 | Nov 21, 2023, 04:20 PM | |
XERS | Xeris Biopharma Holdings, Inc. | Pieper Steven | See Remarks | Nov 20, 2023 | Buy | $1.95 | 28,000 | 54,600 | 1,176,912 | Nov 21, 2023, 04:16 PM | |
XERS | Xeris Biopharma Holdings, Inc. | Schmid John P. | Director | Nov 16, 2023 | Buy | $1.51 | 6,500 | 9,815 | 6,500 | Nov 17, 2023, 06:35 PM | |
XERS | Xeris Biopharma Holdings, Inc. | Shannon John Patrick Jr | See Remarks | Nov 17, 2023 | Buy | $1.64 | 30,769 | 50,400 | 1,408,575 | Nov 17, 2023, 05:58 PM | |
XERS | Xeris Biopharma Holdings, Inc. | PERSKY MARLA | Director | Nov 14, 2023 | Buy | $1.58 | 6,370 | 10,058 | 6,370 | Nov 15, 2023, 04:13 PM | |
XERS | Xeris Biopharma Holdings, Inc. | Edick Paul R | See Remarks | Aug 09, 2023 | Buy | $2.38 | 10,000 | 23,794 | 2,288,064 | Aug 09, 2023, 06:57 PM | |
XERS | Xeris Biopharma Holdings, Inc. | Edick Paul R | See Remarks | Dec 13, 2022 | Buy | $1.45 | 20,000 | 29,000 | 1,528,064 | Dec 14, 2022, 04:11 PM | |
XERS | Xeris Biopharma Holdings, Inc. | BORMANN-KENNEDY BARBARA-JEAN ANNE | Director | Jun 08, 2022 | Option Exercise | $2.10 | 15,000 | 31,500 | 15,000 | Jun 09, 2022, 05:15 PM | |
XERS | Xeris Biopharma Holdings, Inc. | Edick Paul R | See Remarks | May 12, 2022 | Buy | $1.40 | 100,000 | 140,380 | 1,508,064 | May 13, 2022, 04:19 PM | |
XERS | Xeris Biopharma Holdings, Inc. | PRESTRELSKI STEVEN | Chief Scientific Officer | Feb 22, 2022 | Sale | $1.55 | 22,456 | 34,906 | 581,008 | Feb 24, 2022, 04:28 PM | |
XERS | Xeris Biopharma Holdings, Inc. | Edick Paul R | See Remarks | Nov 15, 2021 | Buy | $2.28 | 20,000 | 45,664 | 33,430 | Nov 16, 2021, 04:25 PM | |
XERS | Xeris Biopharma Holdings, Inc. | Shannon John Patrick Jr | See Remarks | Nov 11, 2021 | Buy | $2.09 | 40,000 | 83,500 | 303,829 | Nov 12, 2021, 05:12 PM | |
XERS | Xeris Biopharma Holdings, Inc. | Shannon John Patrick Jr | See Remarks | Nov 12, 2021 | Buy | $2.10 | 60,000 | 126,000 | 363,829 | Nov 12, 2021, 05:12 PM | |
XERS | Xeris Biopharma Holdings, Inc. | Edick Paul R | See Remarks | Nov 11, 2021 | Buy | $2.08 | 200,000 | 415,760 | 808,064 | Nov 12, 2021, 05:09 PM | |
XERS | Xeris Biopharma Holdings, Inc. | Pieper Steven | See Remarks | Nov 10, 2021 | Buy | $2.00 | 25,000 | 49,918 | 183,108 | Nov 12, 2021, 05:06 PM |